Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 3,363,484,400
  • Market Capitalization, $K 3,363,484
  • Shares Outstanding, K 44,175
  • 60-Month Beta 1.68
  • Price/Earnings ttm 17.99
  • Annual Dividend & Yield 0.00 (0.01%)
  • Most Recent Dividend 0.001 on 12/20/19
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.94 +18.94%
on 03/18/20
94.69 -20.94%
on 03/05/20
-15.21 (-16.89%)
since 03/03/20
3-Month
62.94 +18.94%
on 03/18/20
98.76 -24.20%
on 02/19/20
-18.50 (-19.82%)
since 01/03/20
52-Week
62.94 +18.94%
on 03/18/20
98.79 -24.22%
on 12/26/19
-17.82 (-19.23%)
since 04/03/19

Most Recent Stories

More News
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development

The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.

JNJ : 134.17 (+0.77%)
SNY : 44.83 (+3.03%)
DVAX : 3.17 (-8.38%)
PFE : 33.64 (+2.34%)
MRNA : 34.84 (+4.94%)
GSK : 37.14 (-1.49%)
NVAX : 15.61 (+12.63%)
TBIO : 9.53 (+4.84%)
EBS : 57.66 (+1.10%)
IBB : 106.25 (-1.35%)
XLV : 86.78 (-0.90%)
IMV : 1.6900 (+6.96%)
VHT : 162.13 (-1.12%)
HTBX : 0.5000 (-7.77%)
XBI : 74.86 (-1.41%)
5 Low-Cost Top-Ranked ETFs to Tap at Discounted Prices

Grab these ETFs that have a solid Zacks Rank and are available at extremely low prices. These funds have a low expense ratio too.

XLB : 42.61 (-2.40%)
XBI : 74.86 (-1.41%)
FTEC : 59.74 (-1.84%)
XWEB : 59.88 (-1.03%)
SCHV : 42.73 (-1.52%)
Technology & Biotech: 2 ETFs to Watch on Outsized Volume

XLK and XBI saw massive trading volumes in yesterday trading.

XLK : 77.12 (-1.54%)
SPY : 248.19 (-1.45%)
QQQ : 183.37 (-1.42%)
DIA : 210.60 (-1.57%)
XBI : 74.86 (-1.41%)
4 Sector ETF Winners of Bull Market Look Resilient to Virus

These sector ETFs emerged winners in the 11-year old bull market and may survive despite the coronavirus scare.

VCR : 136.25 (-1.52%)
XBI : 74.86 (-1.41%)
FBT : 129.41 (-1.12%)
XLY : 92.41 (-1.74%)
PJP : 54.37 (-0.64%)
FDN : 117.99 (-0.97%)
FXH : 71.36 (-1.38%)
QTEC : 80.37 (-1.56%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 45.17 (-1.45%)
JNJ : 134.17 (+0.77%)
LLY : 139.66 (-1.77%)
BMY : 55.53 (+0.58%)
IBB : 106.25 (-1.35%)
XBI : 74.86 (-1.41%)
ETFs to Play as Goldman Lowers US Q1 GDP Outlook

We discuss some ETF areas that investors can tap as aggravating coronavirus outbreak lead to a cut in U.S. GDP growth forecast.

NKE : 78.86 (-1.60%)
AAPL : 241.41 (-1.44%)
DIS : 93.88 (-3.19%)
IBB : 106.25 (-1.35%)
ICLN : 9.20 (-0.76%)
LQD : 121.10 (-0.52%)
TAN : 23.82 (-2.85%)
XBI : 74.86 (-1.41%)
BBH : 128.32 (-0.77%)
FBT : 129.41 (-1.12%)
VCIT : 86.24 (-0.27%)
AGG : 114.98 (+0.07%)
SPHQ : 29.46 (-1.17%)
QCLN : 18.51 (-0.64%)
BND : 85.96 (-0.05%)
Can Biotech ETFs Gain on Mixed Q4 Earnings Results?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q4 earnings releases.

BIIB : 300.51 (-1.30%)
ALXN : 89.77 (-0.64%)
GILD : 78.21 (+1.60%)
AMGN : 205.41 (-1.66%)
IBB : 106.25 (-1.35%)
XBI : 74.86 (-1.41%)
BBH : 128.32 (-0.77%)
FBT : 129.41 (-1.12%)
Diodes (DIOD) Q4 Earnings and Revenues Top Estimates

Diodes (DIOD) delivered earnings and revenue surprises of 3.17% and 0.39%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 300.51 (-1.30%)
ALXN : 89.77 (-0.64%)
GILD : 78.21 (+1.60%)
AMGN : 205.41 (-1.66%)
IBB : 106.25 (-1.35%)
XBI : 74.86 (-1.41%)
BBH : 128.32 (-0.77%)
FBT : 129.41 (-1.12%)
VAREX IMAGING (VREX) Q1 Earnings Miss Estimates

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -25.00% and 4.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 300.51 (-1.30%)
ALXN : 89.77 (-0.64%)
GILD : 78.21 (+1.60%)
AMGN : 205.41 (-1.66%)
IBB : 106.25 (-1.35%)
XBI : 74.86 (-1.41%)
BBH : 128.32 (-0.77%)
FBT : 129.41 (-1.12%)
Western Union (WU) Q4 Earnings and Revenues Lag Estimates

Western Union (WU) delivered earnings and revenue surprises of -11.63% and -1.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 300.51 (-1.30%)
ALXN : 89.77 (-0.64%)
GILD : 78.21 (+1.60%)
AMGN : 205.41 (-1.66%)
IBB : 106.25 (-1.35%)
XBI : 74.86 (-1.41%)
BBH : 128.32 (-0.77%)
FBT : 129.41 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 77.79
1st Resistance Point 76.33
Last Price 74.86
1st Support Level 73.70
2nd Support Level 72.53

See More

52-Week High 98.79
Fibonacci 61.8% 85.10
Fibonacci 50% 80.86
Fibonacci 38.2% 76.63
Last Price 74.86
52-Week Low 62.94

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar